Why R&D innovation holds the key to greater patient impact
European Pharmaceutical Review
MAY 2, 2023
3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7
99 
Let's personalize your content